
Cell MedX Corp.: Pioneering diabetes research and therapeutic product development for disease management.
Cell MedX Corp. is a research and development company focused on pioneering diabetes research and therapeutic product development. The company aims to discover, design, develop, manufacture, and commercialize clinical therapeutic and wellness products that empower individuals to manage their health and general wellness. A key product, the eBalance®, utilizes microcurrent therapeutic technology to aid in disease management, particularly for diabetes and related complications.
Publicly traded on the OTC Markets under the symbol CMXC, Cell MedX has made significant strides in the field of diabetes treatment. The company's innovative approach and commitment to health management have positioned it as a notable player in the therapeutic product market. Through its advanced technologies, Cell MedX continues to impact patient care by providing effective tools for managing chronic illnesses.

SymbioCellTech
symbiocelltech.com

MelliCell
mellicell.com

Stemedica Cell Technologies
stemedica.com

Cell Care Therapeutics
cell-care.com

ViaCyte

Endogenex
endogenex.com

Encellin
encellin.com

EndoCellutions
endocellutions.com

Cellvie
cellvie.bio

Pathfinder Cell Therapy

Cellular Approaches
International Stem Cell

HebeCell
hebecellcorp.com

Celularity
celularity.com

PharmaCyte Biotech
pharmacyte.com
Companies similar to StimCell Energetics include SymbioCellTech, MelliCell, Stemedica Cell Technologies and Cell Care Therapeutics.
StimCell Energetics was founded in 2014.
StimCell Energetics' headquarters is located in Carson City, NV, US.
StimCell Energetics' most recent funding round was for $26k (USD) in April 2020.
As of Apr 3, 2020, StimCell Energetics has raised a total of $221k (USD).
StimCell Energetics has 2 employees as of Feb 6, 2024.